LinkedIn · Jul 2026
Profile update describing Zealth-AI's evolution from a healthcare AI company to a boutique advisory practice, while noting the original CareShare platform, funding from Y Combinator and Antler, and hospital/customer traction.
Software for remote monitoring of cancer patients
Public company, workplace, funding, and market signals
Zealth AI (ZealthLife Technologies Pte. Ltd.) is a Singapore-founded healthcare AI company that built CareShare for remote oncology monitoring and now presents itself as a healthcare AI consultancy / venture studio serving hospitals, pharma, insurers, and digital health teams.
Primary product
CareShare, an AI-powered remote monitoring platform for cancer patients, plus healthcare AI strategy/advisory services.
Founded
2020
Headquarters
Singapore (128 Prinsep Street / Found8)
Team size
1-10
Work style
Flexible
Industry
Healthtech / Wellness and Fitness Services
Sub-industry
Remote patient monitoring, oncology digital health, and healthcare AI advisory
Offices
0 jobs at Zealth
Check back later for new openings
Business model
Stage
Seed
Total raised
$225K
Latest round
Seed · Jan 2022
Leadership
Co-Founder & CEO
Founders
Co-Founder & CTO
Investors
Founder-led, mission-driven healthcare team with a fast-paced operating style and a strong emphasis on keeping patients continuously connected to clinicians.
Work style
Flexible
Compensation
No public full-time salary bands found; public internship listings show approximate stipends in the ₹6k-₹20k/month range depending on role.
Benefits
Pricing
B2B subscription charged on a per-patient basis for hospitals, with advisory engagements likely project-based.
Differentiators
Technology
Customers
Competitors
Estimated revenue
Approximately $1M annual revenue (2024 estimate)
Estimated monthly visits
1.3K
LinkedIn · Jul 2026
Profile update describing Zealth-AI's evolution from a healthcare AI company to a boutique advisory practice, while noting the original CareShare platform, funding from Y Combinator and Antler, and hospital/customer traction.
ReadySetLaunch · Jun 2026
Recent case study describing Zealth's early MVP as an SMS-based symptom tracking system for cancer patients, launched in about eight weeks, with reported early readmission reduction and lower patient travel time.
LinkedIn · Apr 2026
Founder commentary on retention challenges in healthtech; useful as a current public signal on the operating lessons behind the company and its current thinking.
Venture Insider · Jan 2022
Founder interview covering the origin of Zealth-AI, Antler's first cheque, YC scaling, early pivots, and the company's remote monitoring thesis.
YourStory · Sep 2020
Early profile describing the product, B2B subscription model, hospital customers, and the COVID-era pivot from the original cancer-monitoring thesis.